Anti-RNF20 antibody [RP23040124]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Multiclonal RNF20 antibody. Suitable for ICC/IF, WB and reacts with Human, African green monkey samples. Immunogen corresponding to Recombinant Fragment Protein within Human RNF20.
View Alternative Names
BRE1A, RNF20, E3 ubiquitin-protein ligase BRE1A, BRE1-A, hBRE1, RING finger protein 20, RING-type E3 ubiquitin transferase BRE1A
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-RNF20 antibody [RP23040124] (AB313445)
Immunofluorescent analysis of HCT 116 cells fixed using 4% formaldehyde (reconstituted in 1X PBS) for 10 min at room temperature and permeabilized using 0.1 % Triton X-100 in PBS for 15 min at room temperature labeling RNF20 with ab313445 at 2 µg/mL followed by Goat anti-Rabbit IgG (H+L) ? Secondary Antibody, Alexa Fluor® 488 conjugate at 1/2000 dilution. Panel a) shows representative cells that were stained for detection and localization of RNF20 protein (green), Panel b) is stained for nuclei (blue) using DAPI. Panel c) represents cytoskeletal F-actin staining using Alexa Fluor® 555 Rhodamine Phalloidin at 1/300 dilution. Panel d) is a composite image of Panels a, b and c clearly demonstrating nuclear localization of RNF20. Panel e) represents control cells with no primary antibody to assess background.
- WB
Supplier Data
Western blot - Anti-RNF20 antibody [RP23040124] (AB313445)
All lanes:
Western blot - Anti-RNF20 antibody [RP23040124] (ab313445) at 1 µg/mL
Lane 1:
A549 cell lysate at 30 µg
Lane 2:
Hep G2 cell lysate at 30 µg
Lane 3:
K562 cell lysate at 30 µg
Lane 4:
HEK-293 cell lysate at 30 µg
Lane 5:
NTERA-2 cell lysate at 30 µg
Lane 6:
Cos-7 cell lysate at 30 µg
Lane 7:
HeLa cell lysate at 30 µg
Lane 8:
Jurkat cell lysate at 30 µg
Lane 9:
MCF7 cell lysate at 30 µg
Lane 10:
PC-3 cell lysate at 30 µg
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/2500 dilution
Predicted band size: 113.662 kDa
Observed band size: 120 kDa
true
Reactivity data
Product details
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
- - The sensitivity of polyclonal antibodies by recognising multiple epitopes
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
View our range of recombinant multiclonal antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RNF20 works within the ubiquitination system and forms part of the RNF20/RNF40 complex. This complex plays a role in the monoubiquitination of histone H2B at lysine 120 (H2BK120ub) a significant post-translational modification influencing transcriptional regulation. The modification aids in recruiting downstream effectors and is important for gene expression regulation and DNA damage repair mechanisms.
Pathways
RNF20 interacts with several cellular processes including the DNA damage response and transcriptional activation pathways. It significantly contributes to the DNA repair pathway by facilitating recruitment of repair proteins and is also involved in transcription regulation through the histone modification pathway. Furthermore RNF20 shows a functional relationship with RNF40 another E3 ligase in these pathways emphasizing its integrative role in cellular functioning.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com